May 27, 2020, 10:12 by

Alfa Chemistry announced that a total of close to 800 PEG linker products are now available for its customers worldwide.

May 27, 2020, 10:12 by

AI & Medicine successfully develops an AI-powered drug discovery platform for medical institutions and pharmaceutical enterprises across the globe.

May 27, 2020, 10:12 by

With 60% of trials on hold, Boston pharma tech innovator offers a route for advancing drug development using AI and novel data strategies

May 26, 2020, 10:39 by User Not Found

Clinical Research News Brief | After analyzing the trends in the types of 485,409 people enrolled in 60 studies from 1990 to 2018, Johns Hopkins Medicine researchers report that, although some progress has been made, women and older adults are still vastly underrepresented in lipid lowering therapy trials compared with their disease burden.

May 22, 2020, 04:25 by User Not Found

Clinical Research News | Researchers have found that COVID-19 patients have a high predisposition to developing blood clots. Elsewhere, teams develop a COVID-19 trial finder. We round up the week’s research and industry news for COVID-19.

May 18, 2020, 12:59 by

Clinical Ink has announced a wide-ranging Study Assurance Program to minimize financial impact of the disruption from COVID-19 on new and existing clinical trials.

May 18, 2020, 12:59 by

As one of the most threatening diseases, HIV has been studied for dozens of years. Recently, convertibleCAR-T Cells have been a hot issue in HIV treatment and Creative Biolabs has invited Dr. Eytan Herzig to share some information about it.

May 18, 2020, 12:59 by

A world leader in helium free MRI systems for preclinical research laboratories MR Solutions has now developed the largest and most advanced range of preclinical nuclear medicine combination systems of any manufacturer - MR Solutions’ nuclear medicine range has 34 preclinical scanning configurations.

May 18, 2020, 12:59 by

A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today by Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, and CytoAgents, Inc., a privately held biotechnology company focused on the development of pharmaceutical products for the treatment of viral infectious diseases.

May 18, 2020, 12:58 by

Creative Diagnostics launches SARS-CoV-2 antigens and antibodies for global researchers.

May 18, 2020, 12:58 by

PHARMASEAL, an innovative provider of enterprise trial management solutions expands the capability of the Engility® clinical trial management platform. Electronic trial master file (eTMF) document storage is now available alongside Clinical Trial Management (CTMS) in the same integrated platform with enhanced productivity and operational benefits.

May 18, 2020, 12:58 by

May 18, 2020, 12:58 by

AMRI is increasing production of hydroxychloroquine sulfate API at its Rensselaer, N.Y., manufacturing facility to meet the rise in demand resulting from potential effectiveness of the product in treating COVID-19 symptoms.

May 18, 2020, 12:58 by

HIV continues to be a major global public health issue, having claimed more than 32 million lives so far. However, the increasing access to effective HIV prevention, diagnosis and treatment has made it less threatening. Recently, convertibleCAR-T cell has been a hot issue for its great power to kill HIV-infected cells.

May 18, 2020, 12:58 by

Provider community needs virtual technology, clinical guidance and proven telehealth implementation strategies to combat coronavirus. GlobalMed is offering a free consultative session for care providers, practices, and health systems interested in deploying telehealth.

May 18, 2020, 12:58 by

Free webinar offers insight into pathways to engage with Food and Drug Administration for COVID-19 product development

May 18, 2020, 12:58 by

May 18, 2020, 12:58 by

Noxopharm is the first to achieve a meaningful abscopal responses in prostate cancer. Noxopharm reports a 27% incidence of abscopal response in soft tissue lesions using a combination of Veyonda® and low-dose radiotherapy.

May 18, 2020, 12:58 by

This network uses a secure, cloud-based hub-and-spoke approach to process COVID-19 test orders and direct them efficiently to the nearest laboratory with capacity.

May 18, 2020, 12:58 by

Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, 7T PET-MR imaging system for preclinical research into inflammation, oncology and nephritis.